A citation-based method for searching scientific literature

Amira A Barkal, Rachel E Brewer, Maxim Markovic, Mark Kowarsky, Sammy A Barkal, Balyn W Zaro, Venkatesh Krishnan, Jason Hatakeyama, Oliver Dorigo, Layla J Barkal, Irving L Weissman. Nature 2019
Times Cited: 227







List of co-cited articles
1359 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy.
Jun Wang, Jingwei Sun, Linda N Liu, Dallas B Flies, Xinxin Nie, Maria Toki, Jianping Zhang, Chang Song, Melissa Zarr, Xu Zhou,[...]. Nat Med 2019
150
22

CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells.
Ravindra Majeti, Mark P Chao, Ash A Alizadeh, Wendy W Pang, Siddhartha Jaiswal, Kenneth D Gibbs, Nico van Rooijen, Irving L Weissman. Cell 2009
864
21

Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy.
Amira A Barkal, Kipp Weiskopf, Kevin S Kao, Sydney R Gordon, Benyamin Rosental, Ying Y Yiu, Benson M George, Maxim Markovic, Nan G Ring, Jonathan M Tsai,[...]. Nat Immunol 2018
142
20

Phagocytosis checkpoints as new targets for cancer immunotherapy.
Mingye Feng, Wen Jiang, Betty Y S Kim, Cheng Cheng Zhang, Yang-Xin Fu, Irving L Weissman. Nat Rev Cancer 2019
154
20

CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis.
Siddhartha Jaiswal, Catriona H M Jamieson, Wendy W Pang, Christopher Y Park, Mark P Chao, Ravindra Majeti, David Traver, Nico van Rooijen, Irving L Weissman. Cell 2009
801
18

PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity.
Sydney R Gordon, Roy L Maute, Ben W Dulken, Gregor Hutter, Benson M George, Melissa N McCracken, Rohit Gupta, Jonathan M Tsai, Rahul Sinha, Daniel Corey,[...]. Nature 2017
715
17

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors.
Stephen B Willingham, Jens-Peter Volkmer, Andrew J Gentles, Debashis Sahoo, Piero Dalerba, Siddhartha S Mitra, Jian Wang, Humberto Contreras-Trujillo, Robin Martin, Justin D Cohen,[...]. Proc Natl Acad Sci U S A 2012
722
17

Siglec-mediated regulation of immune cell function in disease.
Matthew S Macauley, Paul R Crocker, James C Paulson. Nat Rev Immunol 2014
451
17

CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin's Lymphoma.
Ranjana Advani, Ian Flinn, Leslie Popplewell, Andres Forero, Nancy L Bartlett, Nilanjan Ghosh, Justin Kline, Mark Roschewski, Ann LaCasce, Graham P Collins,[...]. N Engl J Med 2018
336
15

Tumour-associated macrophages as treatment targets in oncology.
Alberto Mantovani, Federica Marchesi, Alberto Malesci, Luigi Laghi, Paola Allavena. Nat Rev Clin Oncol 2017
15

CD24 and Siglec-10 selectively repress tissue damage-induced immune responses.
Guo-Yun Chen, Jie Tang, Pan Zheng, Yang Liu. Science 2009
470
15

The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9.
Richard Beatson, Virginia Tajadura-Ortega, Daniela Achkova, Gianfranco Picco, Theodora-Dorita Tsourouktsoglou, Sandra Klausing, Matthew Hillier, John Maher, Thomas Noll, Paul R Crocker,[...]. Nat Immunol 2016
120
15

Tumor-associated macrophages: from mechanisms to therapy.
Roy Noy, Jeffrey W Pollard. Immunity 2014
14

Targeting macrophages: therapeutic approaches in cancer.
Luca Cassetta, Jeffrey W Pollard. Nat Rev Drug Discov 2018
422
14

Siglecs and their roles in the immune system.
Paul R Crocker, James C Paulson, Ajit Varki. Nat Rev Immunol 2007
13

Precision glycocalyx editing as a strategy for cancer immunotherapy.
Han Xiao, Elliot C Woods, Petar Vukojicic, Carolyn R Bertozzi. Proc Natl Acad Sci U S A 2016
146
13

Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells.
Michal A Stanczak, Shoib S Siddiqui, Marcel P Trefny, Daniela S Thommen, Kayluz Frias Boligan, Stephan von Gunten, Alexandar Tzankov, Lothar Tietze, Didier Lardinois, Viola Heinzelmann-Schwarz,[...]. J Clin Invest 2018
84
15

Human chimeric antigen receptor macrophages for cancer immunotherapy.
Michael Klichinsky, Marco Ruella, Olga Shestova, Xueqing Maggie Lu, Andrew Best, Martha Zeeman, Maggie Schmierer, Konrad Gabrusiewicz, Nicholas R Anderson, Nicholas E Petty,[...]. Nat Biotechnol 2020
154
13

First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers.
Branimir I Sikic, Nehal Lakhani, Amita Patnaik, Sumit A Shah, Sreenivasa R Chandana, Drew Rasco, A Dimitrios Colevas, Timothy O'Rourke, Sujata Narayanan, Kyriakos Papadopoulos,[...]. J Clin Oncol 2019
140
12

Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion.
Jason E Hudak, Stephen M Canham, Carolyn R Bertozzi. Nat Chem Biol 2014
201
12

Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance.
Camilla Jandus, Kayluz Frias Boligan, Obinna Chijioke, He Liu, Meike Dahlhaus, Thomas Démoulins, Christoph Schneider, Marc Wehrli, Robert E Hunger, Gabriela M Baerlocher,[...]. J Clin Invest 2014
180
12

Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response.
Diane Tseng, Jens-Peter Volkmer, Stephen B Willingham, Humberto Contreras-Trujillo, John W Fathman, Nathaniel B Fernhoff, Jun Seita, Matthew A Inlay, Kipp Weiskopf, Masanori Miyanishi,[...]. Proc Natl Acad Sci U S A 2013
288
12

Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma.
Mark P Chao, Ash A Alizadeh, Chad Tang, June H Myklebust, Bindu Varghese, Saar Gill, Max Jan, Adriel C Cha, Charles K Chan, Brent T Tan,[...]. Cell 2010
574
11

Targeted glycan degradation potentiates the anticancer immune response in vivo.
Melissa A Gray, Michal A Stanczak, Natália R Mantuano, Han Xiao, Johan F A Pijnenborg, Stacy A Malaker, Caitlyn L Miller, Payton A Weidenbacher, Julia T Tanzo, Green Ahn,[...]. Nat Chem Biol 2020
30
36

Macrophages as regulators of tumour immunity and immunotherapy.
David G DeNardo, Brian Ruffell. Nat Rev Immunol 2019
388
10

Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets.
Luca Cassetta, Stamatina Fragkogianni, Andrew H Sims, Agnieszka Swierczak, Lesley M Forrester, Hui Zhang, Daniel Y H Soong, Tiziana Cotechini, Pavana Anur, Elaine Y Lin,[...]. Cancer Cell 2019
225
10

CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer.
Kipp Weiskopf, Nadine S Jahchan, Peter J Schnorr, Sandra Cristea, Aaron M Ring, Roy L Maute, Anne K Volkmer, Jens-Peter Volkmer, Jie Liu, Jing Shan Lim,[...]. J Clin Invest 2016
178
10

Sialic Acid Blockade Suppresses Tumor Growth by Enhancing T-cell-Mediated Tumor Immunity.
Christian Büll, Thomas J Boltje, Natasja Balneger, Sarah M Weischer, Melissa Wassink, Jasper J van Gemst, Victor R Bloemendal, Louis Boon, Johan van der Vlag, Torben Heise,[...]. Cancer Res 2018
66
15

The cellular and molecular origin of tumor-associated macrophages.
Ruth A Franklin, Will Liao, Abira Sarkar, Myoungjoo V Kim, Michael R Bivona, Kang Liu, Eric G Pamer, Ming O Li. Science 2014
659
9

CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis.
Bin-Zhi Qian, Jiufeng Li, Hui Zhang, Takanori Kitamura, Jinghang Zhang, Liam R Campion, Elizabeth A Kaiser, Linda A Snyder, Jeffrey W Pollard. Nature 2011
9

Functional polarization of tumour-associated macrophages by tumour-derived lactic acid.
Oscar R Colegio, Ngoc-Quynh Chu, Alison L Szabo, Thach Chu, Anne Marie Rhebergen, Vikram Jairam, Nika Cyrus, Carolyn E Brokowski, Stephanie C Eisenbarth, Gillian M Phillips,[...]. Nature 2014
9

Sialoglycans and Siglecs Can Shape the Tumor Immune Microenvironment.
Stephanie van de Wall, Kim C M Santegoets, Eline J H van Houtum, Christian Büll, Gosse J Adema. Trends Immunol 2020
33
27

Siglecs as Immune Cell Checkpoints in Disease.
Shiteng Duan, James C Paulson. Annu Rev Immunol 2020
79
11

Engineered SIRPα variants as immunotherapeutic adjuvants to anticancer antibodies.
Kipp Weiskopf, Aaron M Ring, Chia Chi M Ho, Jens-Peter Volkmer, Aron M Levin, Anne Kathrin Volkmer, Engin Ozkan, Nathaniel B Fernhoff, Matt van de Rijn, Irving L Weissman,[...]. Science 2013
254
9

Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages.
Jennifer L Guerriero, Alaba Sotayo, Holly E Ponichtera, Jessica A Castrillon, Alexandra L Pourzia, Sara Schad, Shawn F Johnson, Ruben D Carrasco, Suzan Lazo, Roderick T Bronson,[...]. Nature 2017
236
8

Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy.
Padmanee Sharma, Siwen Hu-Lieskovan, Jennifer A Wargo, Antoni Ribas. Cell 2017
8

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
8

Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy.
Carola H Ries, Michael A Cannarile, Sabine Hoves, Jörg Benz, Katharina Wartha, Valeria Runza, Flora Rey-Giraud, Leon P Pradel, Friedrich Feuerhake, Irina Klaman,[...]. Cancer Cell 2014
685
8


Role of CD47 as a marker of self on red blood cells.
P A Oldenborg, A Zheleznyak, Y F Fang, C F Lagenaur, H D Gresham, F P Lindberg. Science 2000
999
8

Global metabolic inhibitors of sialyl- and fucosyltransferases remodel the glycome.
Cory D Rillahan, Aristotelis Antonopoulos, Craig T Lefort, Roberto Sonon, Parastoo Azadi, Klaus Ley, Anne Dell, Stuart M Haslam, James C Paulson. Nat Chem Biol 2012
216
8


Glycosylation in cancer: mechanisms and clinical implications.
Salomé S Pinho, Celso A Reis. Nat Rev Cancer 2015
8

Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte.
Shyra J Gardai, Kathleen A McPhillips, S Courtney Frasch, William J Janssen, Anna Starefeldt, Joanne E Murphy-Ullrich, Donna L Bratton, Per-Arne Oldenborg, Marek Michalak, Peter M Henson. Cell 2005
894
8

TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy.
Christopher B Rodell, Sean P Arlauckas, Michael F Cuccarese, Christopher S Garris, Ran Li, Maaz S Ahmed, Rainer H Kohler, Mikael J Pittet, Ralph Weissleder. Nat Biomed Eng 2018
294
7

The chemokine system in diverse forms of macrophage activation and polarization.
Alberto Mantovani, Antonio Sica, Silvano Sozzani, Paola Allavena, Annunciata Vecchi, Massimo Locati. Trends Immunol 2004
7

Macrophages and therapeutic resistance in cancer.
Brian Ruffell, Lisa M Coussens. Cancer Cell 2015
645
7

PI3Kγ is a molecular switch that controls immune suppression.
Megan M Kaneda, Karen S Messer, Natacha Ralainirina, Hongying Li, Christopher J Leem, Sara Gorjestani, Gyunghwi Woo, Abraham V Nguyen, Camila C Figueiredo, Philippe Foubert,[...]. Nature 2016
504
7

Understanding the tumor immune microenvironment (TIME) for effective therapy.
Mikhail Binnewies, Edward W Roberts, Kelly Kersten, Vincent Chan, Douglas F Fearon, Miriam Merad, Lisa M Coussens, Dmitry I Gabrilovich, Suzanne Ostrand-Rosenberg, Catherine C Hedrick,[...]. Nat Med 2018
7

Siglec-9 Regulates an Effector Memory CD8+ T-cell Subset That Congregates in the Melanoma Tumor Microenvironment.
Quentin Haas, Kayluz Frias Boligan, Camilla Jandus, Christoph Schneider, Cedric Simillion, Michal A Stanczak, Monika Haubitz, Seyed Morteza Seyed Jafari, Alfred Zippelius, Gabriela M Baerlocher,[...]. Cancer Immunol Res 2019
35
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.